Phosphotungstate Acid Doped Polyanilines Nanorods for in situ NIR-II Photothermal Therapy of Orthotopic Hepatocellular Carcinoma in Rabbit
Introduction
Second near-infrared (NIR-II, 1000~1700 nm) light-activated photothermal therapy (NIR-II PTT) is an emerging tumor treatment method, which utilizes NIR-II absorbing nanomaterials to convert photon energy into hyperthermia for tumor ablation and exhibites low toxicity, small photon scattering, and high maximum permissible exposure (MPE, 1064 nm: 1 W/cm2).1–3 However, the application of NIR-II PTT in the treatment of deep-buried solid tumors was limited due to the low concentration of NIR-II absorption nanomaterials in solid tumors and the inadequate laser energy near the tumor tissues.
To treat the deep-buried carcinoma in situ, NIR-II absorbing nanomaterials were administrated via intravascular injection and deposited into tumor via EPR effect or targeting ligand mediation effect.4–6 However, long accumulation time and low tumor uptake efficiency reduced therapeutic effect due to the excretion by the reticuloendothelial system during systemic circulation. Of these, transarterial infusion provides an optional approach to rapidly and efficiently deliver drugs into the solid tumor with high dose and low systemic toxicity,7 which has been applied in clinical therapy, such as hepatic artery infusion chemotherapy,8–10 radioembolization,11 transcatheter arterial chemoembolization,12,13 and photothermal therapy of tumor.14
To transmit enough laser energy to the deep-buried tumors through malignant tissues deeper than 10 cm, operative exposure is a common option, which has the problem of large damage.15 Optical fibers, which are small (few hundred micrometers in diameter), flexible, nontoxic, and chemically inert, have already proven to be valuable for in vivo clinical applications such as endoscopic procedures, illumination light guides, and laser power transmission for surgical applications.16 Hence, we hypothesize that optical fibers could be inserted into the deep-buried tumors to transmit NIR-II laser energy to deeped buried tumors for in situ NIR-II photothermal therapy. Surprisingly, to date, no study has evaluated the efficacy of in situ NIR-II PTT based on optical fibers transmission of NIR-II laser power and transarterial infusion of NIR-II absorption nanomaterials for treatment of deep-buried tumors, urging a detailed investigation.
Recently, a variety of NIR-II absorbing nanomaterials are applied for the NIR-II photothermal treatment of tumors, including gold nanoparticles,17,18 copper sulfide,19,20 2D materials,21,22 rare-earth doped nanoparticles,23,24 carbon nanotubes,25,26 small organic molecular,27,28 and conjugated polymers.29–31 Compared with other NIR-II absorption nanomaterials, polyanilines have attracted considerable attention due to their distinctive features including strong NIR-II absorbance, desirable photothermal-conversion performance, excellent photostability, pronounced biocompatibility, as well as easy chemical modification.32–34 PANI received special attention in various fields because of their unique π-conjugated structures, which leads to high electrical and proton conductivity in acidic conditions. Its unique redox property is suitable to facile synthesis, inexpensive fabrication, and simple and high doping chemistry. Recently, there has been more growing interest in the potential use of PANI in the field of nanomedicine, including tissue engineering, cell stimulation, or drug delivery.35–37 The potential of PANI with strong NIR-II absorption for treatment of deep buried tumor has been largely neglected and rarely investigated. Moreover, Phosphotungstate acid is an essential member of heteropoly acid, which has been explored as an acid catalyst to degrade organic pollutants.38 However, the insufficient therapeutic efficiency of phosphotungstate acid makes its clinical use impractical. To tackle the aforementioned issues, aniline with phosphotungstic acid and ammonium persulphate to prepare polyaniline nanoparticles by oxidative chemical polymerized, donated as [email protected] Nanorods, which demonstrated strong NIR-II absorbance, excellent photostability, enhanced photothermal conversion efficiency, and good biocompatibility. Moreover, double orthotopic transplantation VX2 tumor rabbit model was fabricated, and [email protected] Nanorods were directly transarterial infused into primary tumor through the tumor feeding artery. Furthermore, an optical fiber was interventionally inserted into the primary VX2 tumor through a catheter to transmit 1064nm laser for in situ NIR-II PTT. In vivo experiments have proven that in situ NIR-II PTT enables the effective thermal ablation of primary tumor, inhibition of distant tumor, and suppression of peritoneal metastasis of orthotopic hepatocellular carcinoma in rabbit. Therefore, this study provides an intriguing strategy to integrate transarterial infusion of NIR-II absorption nanomaterials and in situ NIR-II PTT based on optical fibers transmission of laser power and circumvent the intrinsic limitations of conventional NIR-II PTT against deep-buried solid tumors.
Experimental Section
The Preparation of [email protected] Nanorods
In a typical synthesis procedure of [email protected] Nanorods: aniline (92μL) was added in 15mLDI water to obtain solution A. HPW (188mg) was added into 3mL DI water to provide solution B, which was kept at 4°C. (NH4)2S2O8 (228mg) was added into 10mL DI water to obtain solution C, which was kept at 4°C. Solution A, Solution B, and Solution C were mixed at 4°C. The mixture was kept at 4°C for 10 h. The blue solution was centrifugated under 3000 rpm to remove large particles. [email protected] Nanorods were obtained via centrifugation under 11,000 rpm and extensively washed with DI water and ethanol several times. The calculation of photothermal conversion efficiency, cell culture, in vitro cytotoxicity assay, in vitro photothermal ablation and statistical analysis were provided in the supplementary document.
Animal Models
The models of hepatocellular carcinoma (HCC) in situ and intrahepatic metastases were established in 6 rabbits with the method of ultrasound-guided percutaneous liver puncture. The VX2 tumor tissues were chopped and ground to make tumor cell suspension. VX2 tumor cell suspension (0.2 mL) was intramuscularly injected into the hind leg of the rabbit after intravenous anesthesia. After the tumor matured, the tumor tissue was removed and cut into smaller pieces with a diameter of about 0.1~0.2 cm. Firstly, after the subxiphoid region was depilated and disinfected, the left lobe parenchyma of the rabbit liver was successfully punctured with an 18G PTC needle under the guidance of ultrasound (Mindray ADP1210-01, Shenzhen, China). Secondly, the core of the needle was pulled out and the tumor tissue fragment (0.2 cm in diameter) was pushed into the liver parenchyma with the needle core. Thirdly, the needle was pulled back and punctured in another direction after the injection of the gelatin sponge. A smaller tumor fragment (0.1 cm in diameter) was pushed into the liver about 2~3 cm away from the first implanted tumor. Finally, the big tumor was defined as the primary tumor, and the smaller one was designed as the distal tumor. After the operation, the weight of the rabbits was recorded and the tumor growth was evaluated by ultrasound.
Transarterial Infusion of [email protected] Nanorods and in situ NIR-II PTT
On the 7th day after implantation, the activity of the tumor was evaluated by contrast-enhanced ultrasound. The contrast agent SonoVue (BraccoSulsseSA, Switzerland) was injected through the rabbit ear margin vein, and the dynamic images were acquired until the contrast agent diminished. In addition, the size and location of the tumor were evaluated by CT before treatment. When the tumor had grown to 1 cm, treatment could be started. Rabbits bearing double orthotopic transplantation VX2 tumors were randomly divided into two groups (n=3 per group): transarterial infusion of [email protected] Nanorods as the treatment group and transarterial infusion of PBS as the control group.
A longitudinal incision of about 3 cm was made in the right inguinal area of the anesthetized rabbit to expose the femoral artery. The distal portion of the exposed femoral artery was ligated temporarily to fill the artery. The microcatheter (2.2F 135cm, DonghaiPharmaceutical products Co., Ltd. Japan) was flushed with heparin saline before use. Then, the right femoral artery was punctured with a 21G puncture needle (Cook Incorporated, Bloomington. Indian, USA) visually. After the successful puncture, the micro-guide wire (Transcend, 0.014 in * 205 cm, Boston Scientific Corporation, USA) and the microcatheter were introduced into the artery successively.
Supper selection of the left hepatic artery was performed carefully, and the hepatic artery angiography was done by hand injection of contrast agent to confirm the tip of the microcatheter and the location of the tumor. [email protected] Nanorods (0.5 mg/mL, 8mL) were infused through the microcatheter at a rate of 48 mL/h for 10 minutes. After removing the catheter, the puncture point was pressed for 5 minutes to stop the bleeding, and the incision was stitched. Penicillin was given to fight infection after the operation.
Then, the optical fiber was introduced into orthotopic transplantation of VX2 tumor under the guidance of ultrasound guidance. Firstly, the PTC needle has penetrated the skin and tissue and reached the primary tumor in the liver under the guidance of ultrasound. Secondly, an optical fiber with 220 µm diameter was introduced into the tumor through the PTC needle after the core of which was pulled out. On the other hand, a slim temperature probe was used to monitor the temperature inside the tumor in real-time, while real-time ultrasound imaging was carried out to detect the changes in tumors during in situ NIR-II PTT.
The body weight of all rabbits was also measured and recorded before the operation and on the 3rd, and 14th days after the operation. Ultrasonography was performed on the 1st, 3rd, 5th, 7th, 10th, and 14th day after the operation, and the volume of the primary and distal tumors, as well as the number of intrahepatic metastases, were recorded. On the 14th day after the operation, all tumor-bearing rabbits were euthanized by intravenous injection of the lethal dose of simazine, then the livers were collected and photographed, and the ascites and peritoneal metastases were observed and recorded.
Immune Activation and Pathological Examination
Flow cytometry was used to analyze the immune cells in the distant tumors during [email protected] Nanorods-mediated in situ NIR-II PTT. The blood parameters of all the rabbits were checked before operation and after the operation. The normal liver tissue, heart, spleen, lung, and kidney of the rabbit in the experimental group were fixed with 10% formalin, paraffin-embedded sections, and hematoxylin and eosin (H&E) stained.
Apoptosicratio of VX2 Cells and Cytokine Detection
T cells were separated from spleens at control groups or in situ NIR-II PTT treatment groups and seeded in 96-well microplates with cell density at 10×104 cells per well (0.1 mL). VX 2 cells were added into the T cells of corresponding groups and incubated for 24 h. Then, the supernatant of T cells at different groups were collected by centrifugation. Then, the concentration of IL-2, TNF-α, IFN-γ secreted byT cells were examined by ELISA kits (obtained from Abcam) according to the specifications. The apoptosic VX2 cells were identified by FACS using Annexin V/7aad kit (obtained from Abcam) according to the specifications.
Results and Discussion
Characterization of [email protected] Nanorods
PANI Nanorods were prepared by oxidative chemical polymerization of aniline under phosphotungstic acid and ammonium persulphate. In a typical synthetic process, phosphotungstic acid, ammonium persulphate, and aniline were mixed, and the reaction was carried out at 4°C for 10h (Figure 1A). When the phosphotungstic acid, ammonium persulphate solution was slowly added to aniline mixture in an ice bath, the color of mixed solution changes rapidly from colorless to blue, indicating the successfully oxidation reaction. The mixtures were centrifugated to remove large particles and obtain small [email protected] Nanorods.
The morphologies of the [email protected] Nanorods were characterized using transmission electron microscopy (TEM) and dynamic light scattering (DLS) (Figure 1B and C). The average hydrodynamic size of the [email protected] nanorods was 178 nm, as measured using dynamic light scattering (DLS), with a polydispersity index of 0.114. The zeta potential was 15 mV (Figure S1). Moreover, no aggregation or precipitation was observed in [email protected] Nanorods PBS solution for 22 days (Figure S2), confirming excellent stability. All these results indicated the relatively high stability of [email protected] Nanorods in the physiological milieu.
The [email protected] Nanorods was demonstrated via Fourier transform infrared (FTIR) spectroscopy. As shown in Figure 1D, the peaks of [email protected] Nanorods located at 1530,1396, 1207, and 551 cm−1 were attributed to the bonds from polyaniline. The band at 1078 and 988 cm−1 of [email protected] Nanorods was attributed to phosphotungstate acid. X-ray photoelectron spectroscopy (XPS) in Figure 1E confirmed that [email protected] Nanorods consist of W, O, and C elements. According to the well-resolved peaks, the two strong peaks at 35.1 eV (W 4f7/2) and 33.2 eV (W 4f5/2) correspond to the W (VI) valence state (Figure 1F). All these results confirm the successful fabrication of [email protected] Nanorods.
NIR-II Photothermal Conversion Performance of [email protected] Nanorods
The prepared [email protected] nanorods demonstrated strong optical absorption arranged from 500~1100 nm with blue color dispersed in PBS (Figure 2A). The mass extinction coefficient of [email protected] Nanorods was determined to be 12.53 L/g/cm at 1064 nm, which was much higher than those of TiO2−x (5.54 L/g.cm)39 and SrCuSi4O10 nanosheets (2.42 L/g.cm)40 (Figure 2B). It seems that [email protected] can efficiently collect and convert NIR-II light energy into hyperthermia. The photothermal conversion efficiency at 1064 nm of [email protected] Nanorods was determined to be 57.76% (Figure 2C), which was higher than that of some previously reported conjugated polymer nanoparticles (40~53%),41–44 the gold nanoframeworks (23.9%),45 and MoS2 nanomaterials (43.3%).46 Therefore, all these results verified that [email protected] Nanorods are optional for NIR-II photothermal therapy. To evaluate the photothermal property of [email protected] Nanorods, power intensity- and time-dependent temperature enhancement of [email protected] Nanorods water solutions upon irradiation to 1064 nm laser were detected (Figure 2D–F). The infrared (IR) thermal images were observed using a thermal camera to analyze the corresponding temperature values (Figure S3). Upon the 1064 nm irradiation, the temperature of [email protected] Nanorods solution increased quickly, while the temperature of the water slightly changed under the same condition. After 1064 nm laser (0.7 W/cm2) irradiation for 10 min, the temperature of [email protected] Nanorods solution enhanced about to 70 °C, which was enough to thermal ablate tumor cells. Moreover, the photothermal performance of [email protected] Nanorods under 1064 nm irradiation with different laser power densities was investigated. When the power density of the laser increased, [email protected] Nanorods solution at the same concentration generated more heat. In addition, no significant changes were observed elevating the temperature after five lasers on/off cycles irradiation, confirming the satisfactory photothermal stability of [email protected] Nanorods. Meanwhile, the absorption spectra of [email protected] Nanorods exhibited scarcely a little decline before and after exposure to 1064 nm laser for 20 min (Figure S4), indicating the excellent photothermal conversion stability of [email protected] Nanorods. All these results demonstrated that [email protected] Nanorods could efficiently translate NIR-II light energy to heat, which can be applied in NIR-II PTT.
 |
Figure 2 Photothermal conversion performance of [email protected] Nanorods. (A) The absorption spectrum of [email protected] nanorods with different concentration. (B) Fitting curve of mass extinction coefficient of [email protected] Nanorods at 1064 nm. (C) Linear time constant calculated from the cooling period. (D) The temperature curve of [email protected] Nanorods (40 μg/mL) under 1064 nm laser Irradiation with different power densities. (E) The temperature curve of [email protected] Nanorods with different concentrations under 1064 nm laser exposure (0.7 W/cm2). (F) Temperature rising and cooling cycles of [email protected] Nanorods (40 μg/mL). |
NIR-II Photothermal Therapeutic Effect of [email protected] Nanorods in vitro
Considering the excellent NIR-II absorption capacity of [email protected] Nanorods, in vitro NIR-II photothermal anticancer efficacy was subsequently investigated. The cytotoxicity of [email protected] nanorods to HepG2 liver cancer cells was first evaluated. As shown in Figure 3A, when the concentration of [email protected] Nanorods reached 250 μg/mL, no significant cytotoxicity to HepG2 cells was observed, confirming the excellent biocompatibility of [email protected] Nanorods.
 |
Figure 3 (A) The cytotoxicity of [email protected] Nanorods without or with 1064 nm laser irradiation. (B) The Live/dead staining images of HepG2 cells under different treatments. (C) The flow cytometric analysis of HepG2 cells under different treatments. |
Next, the anticancer performance of [email protected] Nanorods to HepG2 cells in vitro was measured under 1064 nm irradiation. The four different treatment patterns were carried out in the in vitro NIR-II PTT experiments: (1) Control; (2) 1064 nm laser; (3) [email protected] Nanorods; (4) [email protected] Nanorods + 1064 nm laser (NIR-II PTT group). The cell viabilities in the treatment pattern of (1)-(3) were higher than 90%, confirming that 1064 nm laser radiation or [email protected] Nanorods alone did not induce damage to HepG2 cells. However, under the treatment of [email protected] Nanorods plus 1064 nm laser exposure, the relative cell viability declined about 32%. These results proved the killing effect of NIR-II PTT.
Moreover, the viabilities of HepG2 cells after different treatments were visualized through live/dead co-staining, further confirming the excellent effect of NIR-II PTT in vitro. Obviously, cells treated only with [email protected] Nanorods or 1064 nm laser exposure exhibited bright green fluorescence with little red fluorescence. On the contrary, bright red fluorescence was observed in the cells treated by [email protected] Nanorods (100 μg/mL) and 1064 nm laser irradiation (0.7 W/cm2, 5 min), which confirms the therapeutic effect of [email protected] Nanorods based NIR-II PTT (Figure 3B).
Finally, flow cytometry experiments were carried out to investigate the incidence of apoptosis under different treatments. As depicted in Figure 3C, the apoptotic rate of HepG2 cells treated with NIR-II PTT reached 81%, which is superior to that in treated with [email protected] Nanorods or 1064 nm laser irradiation alone. All these data highlighted the great treatment performance of [email protected] Nanorods based NIR-II PTT.
Fabrication the Orthotopic transplantationVX 2 Tumors in Rabbit
Rabbit VX2 tumor is similar to human HCC, due to the hypervascular in tumor and blood supply mainly from hepatic artery.47,48 Moreover, the diameter of the rabbit hepatic artery is enough for catheterization in the hepatic artery. Due to these characteristics, the rabbits bearing double orthotopic transplantation VX2 tumors were fabricated for simulation the growth and metastasis of VX2 liver tumors in situ in the present study (Figure 4A). The VX2 tumor tissue fragments were transplanted into two sites in the left lobe parenchyma of the rabbit liver through the 18-gauge (G) percutaneous transhepatic cholangiography (PTC) needle under ultrasound guidance (Figure 4B). The big tumor was termed as the primary tumor for in situ NIR-II photothermal therapy, while the small one was defined as the distant tumor to investigate the antitumor immunological effect (Figure 4C).
 |
Figure 4 (A) Schematic illustration of the fabrication of the orthotopic transplantation VX2 tumors in the rabbit for antitumor effect. (B) The Ultrasonic imaging of puncture needle during orthotopic transplantation. (C) The Ultrasonic imaging of primary tumor and distant tumor after orthotopic transplantation. |
After orthotopic transplantation, ultrasonic imaging and CT imaging were carried out to confirm the successful fabrication of the double orthotopic transplantation VX2 tumor model in the rabbit. On the 7th day after inoculation, the tumors presented as uniform hypoechoic nodules under the ultrasound scan, with a clear contour and no capsule echo. During the contrast-enhanced ultrasound, the tumor showed a typical sign of “rapid wash-in and wash-out”, peripheral enhancement appeared at the early arterial phase and the contrast agent faded quickly (Figure S5A). To our surprise, the feeding artery could also be seen before the peripheral enhancement. The tumor presented as a low-density mass surrounded by uniform hepatic parenchyma density with a clear boundary on CT scan (Figure S5B and S5C). During the angiography, tumor staining and peripheral neovascularization were observed in the left lobe of the liver (Figure S5D). The blood parameters results showed that there was no significant difference in serum AST and ALT between the experimental group and the control group (Figure S6). All these results confirmed the double orthotopic transplantation VX2 tumor model was successfully established. During the two-week follow-up, no rabbit died and no significant weight loss of the rabbits, which showed that this method was safe, with fewer surgical complications and no unexpected metastasis of other major organs.
Transarterial Infusion of [email protected] and in situ NIR-II PTT
Next, [email protected] Nanorods were directly infused into orthotopic transplantation VX2 tumors through the tumor feeding artery (Figure 5A). The microcatheter was introduced into the left hepatic artery; [email protected] Nanorods were infused into the tumor through the micro-catheter with a rate of 48 mL/h for 10 minutes ([email protected] Nanorods 0.5mg/mL, 8mL). The color of the liquid in the catheter changed from red to blue during the infusion of [email protected] Nanorods as shown in Figure 5B. It seems that [email protected] Nanorods could be rapidly and delivered into HCC tumor tissues with excellent targeting efficiency through the tumor feeding artery, resulting in high drug concentration in the solid tumor and low systemic toxicity through a greater first-pass effect in the liver, which is beneficial for real-time operation and endoscopic image guidance.
 |
Figure 5 (A) Schematic illustration of transarterial infusion of [email protected] Nanorods and in situ NIRII PTT. (B) The photos of femoral artery catheterization and transarterial infusion of [email protected] Nanorods. (C) The photos of in situ NIR-II PTT. (D) Optical fiber was introduced into the tumor through the PTC needle. (E) and (F) Real-time ultrasound scanning during the treatment. |
After transarterial intervention of [email protected] Nanorods in the primary tumor, an 18G PTC needle was used to puncture the primary tumor in the liver under the guidance of ultrasound. The optical fiber with 220 μm diameter was then inserted to the tumor through the PTC needle (Figure 5C). The 1064nm laser energy was transmitted to the primary VX2 tumor through optical fiber to generate hyperthermia. We first investigated the temperature enhancement of primary tumor after in situ 1064 nm laser irradiation. To our surprise, the temperature of primary tumor increased rapidly to 60 °C within 3 minutes, which caused tissue necrosis. However, the temperature of the surrounding normal liver parenchyma remained under 38 °C upon 1064 nm laser radiation. During the photothermal therapy, real-time ultrasound scanning showed that the hypoechoic image of the tumor was quickly replaced by the hyperechoic images, which proved that the temperature in the tumor increased quickly (Figure 5D–F). Compared with the phototherapy therapy of the exposed liver, introducing optical fiber into the tumor in liver is feasible, accurate, and minimally invasive. Moreover, the slender temperature sensor was introduced to monitor the process of temperature rise of the tumor, which is much more accurate than the surface thermometer.49 It seems that the introduction of optical fiber greatly improved the efficiency of photothermal ablation and decreased thermal damage to normal liver parenchyma.
Inspired by the excellent temperature enhancement in tumors induced by [email protected] Nanodtos under 1064nm laser radiation, in vivo experiments with the double VX2 tumor-bearing rabbit model were carried out. Rabbits bearing double orthotopic transplantation VX2 tumors were randomly divided into two groups (n=3 per group): transarterial infusion of [email protected] Nanorods as the treatment group and transarterial infusion of PBS as the control group. After transarterial infusion of [email protected] Nanorods or PBS, an optical fiber transmitted 1064nm laser energy (0.8W/cm2, 5 min) for in situ NIR-II PTT of primary tumor. The surveillance of the primary tumors and distant tumor was recorded after 1, 3, 5, 7, 10, and 14 days by ultrasound (US) to explore the tumor development process (Figure S7 and S8). After in situ NIR-II PTT, primary tumors significantly diminished the volume or even almost vanished, which confirmed that in situ NIR-II PTT could ablate the tumors efficiently (Figure 6A and B). On the contrary, the control group exhibited no prominent antitumor effect on primary tumors. Furthermore, the volume of distant tumors significantly decreased in the treatment group, which proved that in situ NIR-II photothermal therapy could inhibit distant tumors (Figure 6C and D, and Figure S9). However, no tumor inhibition effect on distant tumor in the control group was observed. All these results confirmed that in situ NIR-II PTT treatment could ablate primary tumors and inhibit distant tumors.
 |
Figure 6 Antitumor effects and suppression metastasis of in situ NIR-II PTT in vivo. The tumor development process of primary tumors, (A) The tumor volume growth curves of primary tumors, (B) The ultrasonic imaging of primary tumors. (C) The tumor volume growth curves of distant tumors. (D) The ultrasonic imaging of distant tumors. (E) The photo and the number of metastases of the liver after different treatments. (F) The graph and the number of metastases of peritoneum after different treatments. (G) The H&E staining of tumor tissues. |
Tumor metastasis is the major cause of the high tumor mortality rate, and inhibition of tumor metastasis is of significant importance for cancer treatments. On day 14, livers of both experimental and control groups were harvested to explore tumor metastasis. The tumor specimens of the control group demonstrated a fresh “fish-like” appearance, while those of the experimental group exhibited a pale hard nodule wrapped in red granulation tissue without a capsule, and most tumor centers have scorch marks due to the high temperature. Moreover, multiple large metastases were observed in the control group, while the treatment group produced few metastases (Figure 6E). The tumor tissue of the experimental group was replaced by a large number of necrotic tissues compared to that of the control group (Figure 6G). To our surprise, no significant metastasis in the peritoneum of the treated rabbit was observed. On the contrary, the rabbit in the control group produced distinct metastatic nodules in the peritoneum (Figure 6F). In short, these results confirmed that in situ NIR-II photothermal therapy based on [email protected] Nanorods can suppress tumor metastasis.
Studies were thus carried out to evaluate immune antitumor activity of in situ NIR-II PTT. Therefore, the ratio of CD3+CD8+T cells in distant tumors was analyzed. Compared with control group, the tumor infiltrations of the CD3+ T cells and CD8+ T cells in in situ NIR-II PTT group were significantly increased (Figure 7A and B). This result demonstrated that in situ NIR-II PTT treatment effectively increased the infiltration of CD8+ T cells into tumor.
 |
Figure 7 (A) Representative flow cytometry plots of CD3+ and CD8+ T cells in distant tumor after different treatment. (B) The proportions of CD3+ and CD8+ T cells in distant tumor after different treatment. (C) Representative flow cytometry plots of VX 2 cells after co-cultured with T lymphocyte stimulated from spleen from different treatment group. (D) The proportions of apoptotic VX2 cells after co-cultured with T lymphocyte stimulated from spleen from different treatment groups. The cytokines concentration of IL-2 (E), TNF-α (F), and IFN-γ (G) secreted by T lymphocyte stimulated from spleen with the VX2 cells from different treatment group. (H) Detection of Ki67 expression in primary tumor and N-cadherin and Vimentin expression in distant tumor were performed by IHC. |
To further investigate the antitumor immunity of in situ NIR-II PTT, we isolated T cells from spleens in the control or in situ NIR-II PTT group and then co-cultured with VX2 cells for 24 hours in vitro. The apoptosic VX2 cells were identified by FACS using Annexin V/7aad kit and the concentration of cytokine IL-2, TNF-α, and IFN-γ supernatant were detected by ELISA kits. As shown in Figure 7C and D, it could be obviously noticed that the ratio of apoptosic cells in the treatment group was substantially higher as compared with control group. Moreover, compared with control group, a much higher level of IL-2, TNF-α, and IFNγwere induced by in situ NIR-II PTT treatment group (Figure 7E–G). As shown in Figure 7H, the IHC staining was performed on the tumors in the treatment group and the control group. Compared with the control group, the expression of Ki67 in the treatment group was significantly lower. In order to evaluate the ability of the tumor invasion and metastasis, the expression levels of N-cadherin and Vimentin were detected in this study. The results showed that the expression of N-cadherin and Vimentin in distant tumors in the treatment group was significantly down-regulated. Collectively, our results indicated that in situ NIR-II PTT can not only led to the rapid destruction of primary tumor tissue, but also stimulate specificity immunity to inhibit the growth of distant tumor and suppress peritoneal metastasis.
Biocompability of [email protected]
Furthermore, the potential systemic damage during [email protected] Nanorods mediated in situ NIR-II PTT was exploited. No distinct body weight loss was observed during in situ NIR-II PTT (Figure S10). Moreover, the main organs (heart, liver, lung, spleen, and kidney) after NIR-II PTT treatment exhibited no obvious pathological abnormalities or disorders, confirming the high biosafety of [email protected] Nanorods (Figure S11). In addition, blood panel analysis was carried out after transarterial infusion of [email protected] Nanorods (Figure S12). The blood markers, including creatinine (CR), white blood cells (WBC), platelets (PLT), and, hemoglobin (HGB), were within the normal reference ranges. Herein, all the above findings verified [email protected] Nanorods based in situ NIR-II PTT has ignorable systemic biological toxicity.
Conclusion
In conclusion, we provided a novel strategy of in situ NIR-II PTT based on optical fiber transmission of laser energy and transarterial infusion of NIR-II absorbing [email protected] Nanorods for treatment of orthotopic transplantation VX2 tumor in the rabbit. [email protected] Nanorods were prepared via oxidative chemical polymerization, which exhibited strong NIR-II absorption, higher photothermal conversion efficiency, and excellent biocompatibility. Orthotopic transplantation VX2 tumor rabbit model was fabricated, then [email protected] Nanorods were rapidly delivered into the VX2 tumor via transarterial infusion. Moreover, an optical fiber was inserted into in situ VX2 tumors and transmitted 1064nm laser energy for in situ NIR-II PTT. Furthermore, in vivo experiments confirmed that in situ NIR-II PTT could ablate primary tumor, inhibit distant tumor, and suppress the peritoneal metastasis. This study offers new options for improving in situ NIR-II PTT for the treatment of deep-buried solid tumors.
Ethics Statement
All animal procedures were performed in accordance with the Guidelines for Care and Use of Laboratory Animals of Southern Medical University. The present study was approved by the Nanfang hospital animal ethic committee (No: NFYY-2021-0531). Twelve New Zealand white rabbits (weighing 2.5~3 kg), aged from 2 to 3 months, were provided and raised by the Experimental Animal Center, Nanfang Hospital (China). And the HepG2 cells used in this study were purchased from China National Laboratory Cell Resource Sharing Platform.
Acknowledgments
This work was financially supported by the National Natural Science Foundation of China (Grant No. 81902865) and China Postdoctoral Science Foundation (2021M690073).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Chen S, Sun B, Miao H, et al. NIR-II dye-based multifunctional telechelic glycopolymers for NIR-iia fluorescence imaging-guided stimuli-responsive chemo-photothermal combination therapy. ACS Mater Lett. 2020;2(2):174. doi:10.1021/acsmaterialslett.9b00480
2. Dai H, Wang X, Shao J, et al. NIR-II organic nanotheranostics for precision oncotherapy. Small. 2021;2(44):2102646. doi:10.1002/smll.202102646
3. Zhen X, Pu K, Jiang X. Photoacoustic imaging and photothermal therapy of semiconducting polymer nanoparticles: signal amplification and second near-infrared construction. Small. 2021;17(6):2004723. doi:10.1002/smll.202004723
4. Dai R, Peng X, Lin B, Xu D, Lv R. NIR II luminescence imaging for sentinel lymph node and enhanced chemo-/photothermal therapy for breast cancer. Bioconjug Chem. 2021;32:2117. doi:10.1021/acs.bioconjchem.1c00393
5. Wang Y, Wang Z, Xu C, Tian H, Chen X. A disassembling strategy overcomes the EPR effect and renal clearance dilemma of the multifunctional theranostic nanoparticles for cancer therapy. Biomaterials. 2019;197:284. doi:10.1016/j.biomaterials.2019.01.025
6. Lin Z, Goswami N, Xue T, et al. Engineering metal nanoclusters for targeted therapeutics: from targeting strategies to therapeutic application. Adv Funct Mater. 2021;31:2105662. doi:10.1002/adfm.202105662
7. Zhang C, Sun W, Wang Y, et al. Gd-/CuS-loaded functional nanogels for MR/PA imaging-guided tumor-targeted photothermal therapy. ACS Appl Mater Interfaces. 2020;12:9107. doi:10.1021/acsami.9b23413
8. Gao L, Yan H, Zhu S, et al. Targeted delivery of Bi2Se3 Nanoflowers to orthotopic liver tumor via transarterial infusion for enhanced microwave ablation sensibilization. Nano Today. 2021;41:101314. doi:10.1016/j.nantod.2021.101314
9. Xie Y, Qi X, Xu K, et al. Transarterial infusion of iRGD-modified ZrO 2 nanoparticles with lipiodol improves the tissue distribution of doxorubicin and its antitumor efficacy. J VascInterv Radiol. 2019;30:2026. doi:10.1016/j.jvir.2019.04.014
10. Zhang Y-Q, Jiang L-J, Jiang S-X, et al. Gefitinib with or without transarterial infusion chemotherapy (cisplatin) for large nonsmall cell lung cancer with epidermal growth factor receptor mutations. J VascInterv Radiol. 2019;30:1004.
11. Anteby R, Kemeny NE, Kingham TP, et al. Getting chemotherapy directly to the liver: the historical evolution of hepatic artery chemotherapy. J Am Coll Surg. 2021;232(3):332. doi:10.1016/j.jamcollsurg.2020.11.013
12. Li R, Li D, Jia G, Li X, Sun G, Zuo C. Diagnostic performance of theranostic radionuclides used in transarterial radioembolization for liver cancer. Front Oncol. 2021;10:551622. doi:10.3389/fonc.2020.551622
13. Vogl TJ, Gruber-Rouh T. HCC: transarterial therapies-what the interventional radiologist can offer. Dig Dis Sci. 2019;64(4):959. doi:10.1007/s10620-019-05542-5
14. Pang H, Tian C, He G, et al. NIR-absorbing Prussian blue nanoparticles for transarterial infusion photothermal therapy of VX2 tumors implanted in rabbits. Nanoscale. 2021;13(18):8490. doi:10.1039/D1NR01394G
15. Abbass MA, Ahmad SA, Mahalingam N, et al. In vivo ultrasound thermal ablation control using echo decorrelation imaging in rabbit liver and VX2 tumor. PLoS One. 2019;14(12):0226001. doi:10.1371/journal.pone.0226001
16. Katzir A. optical fiber techniques for medical applications. In: Meyers RA, editor. Encyclopedia of Physical Science and Technology. 3rd ed. Academic Press; 2003:315–333.
17. Shen J, Karges J, Xiong K, et al. Cancer cell membrane camouflaged iridium complexes functionalized black-titanium nanoparticles for hierarchical-targeted synergistic NIR-II photothermal and sonodynamic therapy. Biomaterials. 2021;275:120979. doi:10.1016/j.biomaterials.2021.120979
18. Tabish TA, Dey P, Mosca S, et al. Smart gold nanostructures for light mediated cancer theranostics: combining optical diagnostics with photothermal therapy. Adv Sci. 2020;7(15):1903441. doi:10.1002/advs.201903441
19. Hu R, Fang Y, MI. H, et al. Ultrasmall Cu 2-x S nanodots as photothermal-enhanced Fenton nanocatalysts for synergistic tumor therapy at NIR-II biowindow. Biomaterials. 2019;206:101. doi:10.1016/j.biomaterials.2019.03.014
20. Wang S, Hu T, Wang G, et al. Ultrathin CuFe2S3 nanosheets derived from CuFe-layered double hydroxide as an efficient nanoagent for synergistic chemodynamic and NIR-II photothermal therapy. Chem Eng J. 2021;419:129458. doi:10.1016/j.cej.2021.129458
21. Zhang Q, Guo Q, Chen Q, et al. Highly efficient 2D NIR-II photothermal agent with fenton catalytic activity for cancer synergistic photothermal-chemodynamic therapy. Adv Sci. 2020;7(7):1902576. doi:10.1002/advs.201902576
22. An D, Fu J, Zhang B, et al. NIR-II responsive inorganic 2D nanomaterials for cancer photothermal therapy: recent advances and future challenges. Adv Funct Mater. 2021;31(32):2101625. doi:10.1002/adfm.202101625
23. Jiang M, Liu H, Zeng S, Hao J. A general in situ growth strategy of designing theranostic NaLnF 4 @Cu 2− x S nanoplatform for in vivo NIR-II optical imaging beyond 1500 nm and photothermal therapy. Adv Therap. 2019;2(6):1800153. doi:10.1002/adtp.201800153
24. Xiang H, Lin H, Yu L, Chen Y. Hypoxia-irrelevant photonic thermodynamic cancer nanomedicine. ACS Nano. 2019;13(2):2223. doi:10.1021/acsnano.8b08910
25. Li Y, Bai G, Zeng S, Hao J. Theranostic carbon dots with innovative NIR-II emission for in vivo renal-excreted optical imaging and photothermal therapy. ACS Appl Mater Interfaces. 2019;11(5):4737. doi:10.1021/acsami.8b14877
26. Geng B, Qin H, Shen W, et al. Carbon dot/WS2 heterojunctions for NIR-II enhanced photothermal therapy of osteosarcoma and bone regeneration. Chem Eng J. 2020;383:123102. doi:10.1016/j.cej.2019.123102
27. Jiang Z, Zhang C, Wang X, et al. A borondifluoride-complex-based photothermal agent with an 80 % photothermal conversion efficiency for photothermal therapy in the NIR-II window. Angew Chem Int Ed. 2021;60(41):22376. doi:10.1002/anie.202107836
28. Tang B, Li W-L, Chang Y, et al. A supramolecular radical dimer: high-efficiency NIR-II photothermal conversion and therapy. Angew Chem Int Ed. 2019;58(43):15526. doi:10.1002/anie.201910257
29. Yin C, Li X, Wang Y, et al. Organic semiconducting macromolecular dyes for NIR-II photoacoustic imaging and photothermal therapy. Adv Funct Mater. 2021;31(37):2104650. doi:10.1002/adfm.202104650
30. Xu C, Jiang Y, Han Y, Pu K, Zhang R. A polymer multicellular nanoengager for synergistic NIR-II photothermal immunotherapy. Adv Mater. 2021;33(14):2008061. doi:10.1002/adma.202008061
31. Li J, Jiang R, Wang Q, et al. Semiconducting polymer nanotheranostics for NIR-II/Photoacoustic imaging-guided photothermal initiated nitric oxide/photothermal therapy. Biomaterials. 2019;217:119304. doi:10.1016/j.biomaterials.2019.119304
32. Zhang Y, Wang Y, Yang X, Yang Q, Li J, Tan W. Polyaniline nanovesicles for photoacoustic imaging-guided photothermal-chemo synergistic therapy in the second near-infrared window. Small. 2020;16(35):2001177. doi:10.1002/smll.202001177
33. Yan L-X, Chen L-J, Zhao X, Yan X-P. pH switchable nanoplatform for in vivo persistent luminescence imaging and precise photothermal therapy of bacterial infection. Adv Funct Mater. 2020;30(14):1909042. doi:10.1002/adfm.201909042
34. Tian Q, Li Y, Jiang S, et al. Tumor pH-responsive albumin/polyaniline assemblies for amplified photoacoustic imaging and augmented photothermal therapy. Small. 2019;15(42):1902926. doi:10.1002/smll.201902926
35. Chiou NR, Lu C, Guan L, Lee J, Epstein AJ. Growth andAlignment of polyaniline nanofibres with superhydrophobic, superhydrophilic and other properties. Nat Nanotechnol. 2007;2(6):354–357. doi:10.1038/nnano.2007.147
36. Gospodinova N, Terlemezyan L. Conducting polymers prepared by oxidative polymerization: polyaniline. Prog Polym Sci. 1998;23(8):1443–1484. doi:10.1016/S0079-6700(98)00008-2
37. Bhadra S, Khastgir D, Singha NK, Lee JH. Progress inPreparation, processing and applications of polyaniline. Prog Polym Sci. 2009;34:783–810.
38. Chen JS, Sankar A, Lin YJ, et al. Phosphotungstic acid as a novel acidic catalyst for carbohydrate protection and glycosylation. RSC Adv. 2019;9(58):33853–33862. doi:10.1039/C9RA06170C
39. Han XX, Huang J, Jing XX, et al. Oxygen-deficient black titania for synergistic/enhanced sonodynamic and photoinduced cancer therapy at near infrared-II biowindow. ACS Nano. 2018;12:4545. doi:10.1021/acsnano.8b00899
40. Yang C, Younis MR, Zhang J, Qu J, Lin J, Huang P. Programmable NIR-II photothermal-enhanced starvation-primed chemodynamic therapy using glucose oxidase-functionalized ancient pigment nanosheets. Small. 2020;16:2001518. doi:10.1002/smll.202001518
41. Sun P, Jiang X, Sun B, et al. Electron-acceptor density adjustments for preparation conjugated polymers with NIR-II absorption and brighter NIR-II fluorescence and 1064 nm active photothermal/gas therapy. Biomaterials. 2022;208:121319. doi:10.1016/j.biomaterials.2021.121319
42. Jiang Y, Li J, Zhen X, Xie C, Pu K. Dual-peak absorbing semiconducting copolymer nanoparticles for first and second near-infrared window photothermal therapy: a comparative study. Adv Mater. 2018;30:1705980. doi:10.1002/adma.201705980
43. Cheng Q, Tian Y, Dang H, et al. Antiquenching macromolecular NIR-II probes with high-contrast brightness for imaging-guided photothermal therapy under 1064 nm irradiation. Adv Healthcare Mater. 2021;11:2101697. doi:10.1002/adhm.202101697
44. Yin C, Tai X, Li X, et al. Side chain engineering of semiconducting polymers for improved NIR-II fluorescence imaging and photothermal therapy. Chem Eng J. 2022;428:132098. doi:10.1016/j.cej.2021.132098
45. Wang JP, Sun JY, Wang YH, et al. Gold nanoframeworks with mesopores for raman-photoacoustic imaging and photo-chemo tumor therapy in the second near-infrared biowindow. Adv Funct Mater. 2020;30:1908825. doi:10.1002/adfm.201908825
46. Zhou Z, Li BW, Shen C, et al. Metallic 1T phase enabling MoS2 nanodots as an efficient agent for photoacoustic imaging guided photothermal therapy in the near-infrared-II window. Small. 2020;16:2004173. doi:10.1002/smll.202004173
47. Khabbaz RC, Huang YH, Smith AA, et al. Development and angiographic use of the rabbit VX2 model for liver cancer. J Vis Exp. 2019;143:e58600.
48. Yi HM, Cai BH, Ai X, Li KY, Zhang W. Establishment of rabbit liver VX2 tumor model using percutaneous puncture inoculation of tumor fragment guided and evaluated by ultrasonography. Curr Med Sci. 2019;39:820. doi:10.1007/s11596-019-2111-6
49. Zhou J, Ling G, Cao J, et al. Transcatheter intra-arterial infusion combined with interventional photothermal therapy for the treatment of hepatocellular carcinoma. Int J Nanomedicine. 2020;15:1373. doi:10.2147/IJN.S233989
